Travere Therapeutics to Present at Upcoming Investor Conferences
Travere Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences:
圣地亚哥,2024年5月8日(环球新闻专线)——Travere Therapeutics, Inc.(纳斯达克股票代码:TVTX)今天宣布,公司管理层将参加以下即将举行的投资者会议:
BofA Securities Health Care Conference
Wednesday, May 15, 2024, at 8:00 a.m. PT
美银证券医疗保健会议
太平洋时间 2024 年 5 月 15 日星期三上午 8:00
Jefferies Global Healthcare Conference
Wednesday, June 5, 2024, at 3:00 p.m. ET
杰富瑞全球医疗保健会议
美国东部时间 2024 年 6 月 5 日星期三下午 3:00
Live webcasts of the presentations will be accessible on the Investor page of Travere's website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.
演讲的网络直播可在特拉弗雷网站的投资者页面ir.travere.com/events-presents-presents上观看。重播将在每场赛事结束后的30天内开放。
About Travere Therapeutics
关于特拉弗疗法
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
在Travere Therapeutics,我们处于生命中罕见的境地。我们是一家生物制药公司,每天齐心协力,帮助不同背景的患者、家属和护理人员应对罕见疾病的生活。在这条道路上,我们知道迫切需要治疗方案,这就是为什么我们的全球团队与罕见病界合作,确定、开发和提供改变生活的疗法。为了实现这一使命,我们不断寻求了解罕见患者的不同视角,勇敢地开辟新的道路,改变他们的生活,为他们带来希望,无论是今天还是未来。欲了解更多信息,请访问 travere.com。
Contact Info
联系信息
Media: 888-969-7879 mediarelations@travere.com |
Investors: 888-969-7879 IR@travere.com |
媒体: 888-969-7879 mediarelations@travere.com |
投资者: 888-969-7879 IR@travere.com |